Anti-IFITM1 antibody [EPR22620-12]
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal IFITM1 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 6 publications.
View Alternative Names
CD225, IFI17, IFITM1, Interferon-induced transmembrane protein 1, Dispanin subfamily A member 2a, Interferon-induced protein 17, Interferon-inducible protein 9-27, Leu-13 antigen, DSPA2a
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
Immunohistochemical analysis of paraffin-embedded human cerebrum tissue labeling IFITM1 with ab233545 at 1/2000 dilution, followed by Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on blood vessels of human cerebrum (PMID : 24603679). Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
The section was incubated with ab233545 for 10 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized K562 (human chronic myelogenous leukemia cell line from bone marrow) or A549 (human lung carcinoma cell line) cells labeling IFITM1 with ab233545 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing membranous staining in K-562 cells. Negative control : A549 (PMID : 25105503). The nuclear cpounter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).
PBS only control : Use PBS instead of primary antibody, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling IFITM1 with ab233545 at 1/2000 dilution, followed by Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on lymphocytes of human tonsil is observed. Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
The section was incubated with ab233545 for 10 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol-fixed K562 (human chronic myelogenous leukemia cell line from bone marrow) (Right) or A549 (human lung carcinoma cell line) (Left) cells labeling IFITM1 with ab233545 at 1/500 (red) compared with a Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue).
Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077), at 1/2000 dilution was used as the secondary antibody.
Negative control : A549 (PMID : 25105503).
- IP
Unknown
Immunoprecipitation - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
IFITM1 was immunoprecipitated from 0.35 mg of K562 (human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate with ab233545 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab233545 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used as secondary antibody at 1/5000 dilution.
Lane 1 : K562 whole cell lysate 10 μg (Input).
Lane 2 : ab233545 IP in K562 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab233545 in K562 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.
All lanes:
Immunoprecipitation - Anti-IFITM1 antibody [EPR22620-12] (ab233545)
Predicted band size: 13 kDa
Observed band size: 17 kDa
false
- WB
Unknown
Western blot - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
Blocking and dilution buffer : 5% NFDM/TBST.
The molecular weight observed is consistent with what has been described in the literature (PMID : 25105503) IFN-α induce the expression of IFITM1(PMID : 27852071).
Negative control : A549 (PMID : 25105503).
All lanes:
Western blot - Anti-IFITM1 antibody [EPR22620-12] (ab233545) at 1/2000 dilution
Lane 1:
K562 (human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate at 20 µg
Lane 2:
A549 (human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 3:
Untreated HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 4:
HeLa, treated with 10ng/ml hIFN-α for 16 hours, whole cell lysate at 20 µg
Lane 5:
TF-1 (human bone marrow erythroleukemia cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 13 kDa
Observed band size: 17 kDa
false
Exposure time: 8s
Related conjugates and formulations (10)
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-IFITM1 antibody [EPR22620-12]
-
Anti-IFITM1 antibody [EPR22620-12] - BSA and Azide free
-
578 PE
PE Anti-IFITM1 antibody [EPR22620-12]
-
HRP Anti-IFITM1 antibody [EPR22620-12]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-IFITM1 antibody [EPR22620-12]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-IFITM1 antibody [EPR22620-12]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-IFITM1 antibody [EPR22620-12]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-IFITM1 antibody [EPR22620-12]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-IFITM1 antibody [EPR22620-12]
-
660 APC
APC Anti-IFITM1 antibody [EPR22620-12]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein inhibits viral entry by restricting the fusion of viral membranes with host cell membranes. IFITM1 does not function alone; it is part of the IFITM family which includes IFITM2 and IFITM3 each contributing to antiviral defense. The protein is strategically positioned to prevent the spread of viruses by blocking them from entering new cells which is important for managing viral propagation.
Pathways
IFITM1 engages the innate immune response pathway responding to viral infections by acting as a barrier to viral entry. It works alongside related proteins such as IFITM2 and IFITM3 within this pathway. IFITM1 is also part of the interferon pathway where its expression is upregulated in response to interferon signals. This relationship highlights its role in the immune response acting as a frontline protector against the invasion of viruses like influenza and others.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
European journal of medical research 30:582 PubMed40619436
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 99:e0127724 PubMed39601593
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Tohoku journal of experimental medicine 264:31-39 PubMed38866531
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of extracellular vesicles 13:e12409 PubMed38321535
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature medicine 28:201-211 PubMed34782790
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:711145 PubMed34659201
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com